Find information on thousands of medical conditions and prescription drugs.

Fortovase

Saquinavir, with trade name Fortovase® is a protease inhibitor used as a component of highly active antiretroviral therapy (HAART). more...

Home
Diseases
Medicines
A
B
C
D
E
F
Captagon
Famohexal
Famotidine
Faslodex
Faslodex
Fasoracetam
Felbamate
Felbatol
Felodipine
Felypressin
Femara
Femara
Fempatch
Femring
Fenfluramine
Fenofibrate
Fentanyl
Fexofenadine
Filgrastim
Filipin
Finasteride
Fioricet
Fiorinal
Flagyl
Flarex
Flavoxate
Flecainide
Flexeril
Flomax
Flonase
Flovent
Floxuridine
Fluacizine
Flucloxacillin
Fluconazole
Flucytosine
Fludarabine
Fludrocortisone
Flumazenil
Flunisolide
Flunitrazepam
Fluocinonide
Fluohexal
Fluorometholone
Fluorouracil
Fluoxetine
Fluphenazine
Flurazepam
Flutamide
Fluticasone
Fluvastatin
Fluvoxamine
FML
Focalin
Folic acid
Follutein
Fomepizole
Formoterol
Fortamet
Fortovase
Fosamax
Fosinopril
Fosinoprilat
Fosmidomycin
Fosphenytoin
Frova
Frovatriptan
Frusehexal
Fulvestrant
Fumagillin
Furazolidone
Furosemide
Furoxone
Fusafungine
Fusidic acid
Fuzeon
G
H
I
J
K
L
M
N
O
P
Q
R
S
T
U
V
W
X
Y
Z

Saquinavir mesylate is a different formulation, designed to be combined with another protease inhibitor that increases the bioavailability of the saquinavir.

History

Saquinavir was the first protease inhibitor (and sixth antiretroviral) approved by the Food and Drug Administration (FDA). It was approved on December 6, 1995, as Invirase®, a poorly-absorbed hard gel capsule which quickly led to viral resistance in many of the pioneer patients.

It was approved again on Nov 7, 1997 as Fortovase®, a soft gel capsule reformulated for improved bioavailability. The manufacturer, Roche, is alleged to have rushed Invirase® to market, but the conditions that prevailed at the time were very bad and there was a lot of pressure to produce products quickly.

Method of activity

When given alone, the HIV Protease Inhibitor (HPI) saquinavir has a very low oral bioavailability. In the clinic, it was found that the oral bioavailability of saquinavir significantly increases when patients also receive the HPI ritonavir. For patients, this has the major benefit that they can take less saquinavir, while maintaining sufficient saquinavir blood plasma levels to efficiently suppress the replication of HIV.

The mechanism behind this welcome observation was not directly known, but later it was determined that ritonavir inhibits the enzyme Cytochrome P450 3A4. Normally, this enzyme metabolizes saquinavir to an inactive form, but with the ritonavir inhibiting this enzyme, the saquinavir blood plasma levels increased considerably. Additionally, ritonavir also inhibits multidrug transporters, although to a much lower extent.


Read more at Wikipedia.org


[List your site here Free!]



SAQUINAVIR - Fortovase or Invirase
The 200 mg saquinavir soft-gel capsules are beige, opaque, soft gelatin capsules imprinted with "ROCHE" and "0246". Other formulations of saquinavir ...
Therapeutic and diagnostic advances in the HAART era
It has been almost 10 years since the approval of the first protease inhibitor, saquinavir (Invirase) in December 1995. Since that time, there have been great advances in treatment monitoring, trea
HAART at 10—a CFA timeline
Please note: the events and trends listed on this timeline are by year only and are not listed in any particular order within each year. The sources ...
Other FDA advisories
Other FDA Advisories: Recall of urine processing kit. The U.S. Food and Drug Administration (FDA) has issued a Class I recall of the ProbeTec ET Urine ...
Victim of drugs' success?
For the first time in the history of the AIDS epidemic a drug company is halting production on antiretroviral medications because of low demand, and ...
Weekend treatment interruptions for certain well-controlled patients: interview with Cal Cohen, M.D
Dr. Cal Cohen is the research director of the Community Research Initiative of New England, teaches at Harvard Medical School in Boston, and is affiliated ...
MIRIAM HOSPITAL MORBIDITY AND MORTALITY CONFERENCE, A CASE OF FEVER
CASE PRESENTATIONS OF THE BROWN UNIVERSITY DEPARTMENT OF MEDICINE CHIEF COMPLAINT: fever to 40.6°C x 24 hours HISTORY OF PRESENT ILLNESS: This 39 year ...
Combo Approved for HIV Treatment
The FDA approved Roche's saquinavir mesylate (Invirase, 1,000 mg) with ritonavir (Abbott's Norvir, 100 mg) for use in combination regimens for HIV infection ...

Home Contact Resources Exchange Links ebay